
Melanie Sturtevant
1.1K posts

Melanie Sturtevant
@melsturtevant
Love my food, running, and long trips to far away places. Coffee snob. Associate Director of Policy Evidence and Influencing @BreastCancerNow All views my own.



It’s 1st of December. Mull everything. Mull the wine, mull the cider, mull your tea, mull the tap water, mull the cat, mull the toothpaste, mull the carpet, mull the sprouts, mull the chairs. Mull it all! Get your hair cut in a mullet. Mull the Kintyre. Mull the halls with boughs of holly. Get everything mulled. Right now. FULL MULL AHEAD!

Today, alongside Hannah Gardner, Helen Addis and Nadia Sawalha, we met Health and Social Care Secretary @wesstreeting. We urged him to find a way to break the deadlock so that the drug Enhertu, for HER2-low secondary breast cancer, can be made available on the NHS.

‘To make decisions which stop us living fully doesn’t make any sense’ Why has a drug that can extend life for advanced breast cancer patients not been made available on the NHS? @itsanitarani hears from Kate Wills, one of the women affected by the decision on Enhertu ⬇️

BREAKING - #EnhertuEmergency: Thousands of women with incurable HER2-low secondary breast cancer have just been denied access to the drug Enhertu. It’s a drug that would’ve given them the hope of more time to live. But it has been rejected for use on the NHS in England.

Wishing everyone a very merry Christmas 🎄 🌟

'Last Christmas' by Wham is finally Christmas number 1 after a 39 year wait!

BREAKING: NHS planning guidance - which sets the service's delivery plans for next year - has been delayed till January after Treasury refused to sign off on it, and following disruption from deficits and strikes. It's only the second time in 15 years it has come later than Christmas.







Thank you @susannareid100 for sharing the importance of the breast screening programme. The screening programme has helped thousands of women catch breast cancer early, but after years of underfunding the programme is at breaking point.






